• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » We’ve hit the jackpot with A Million Hearts

We’ve hit the jackpot with A Million Hearts

September 21, 2011 By MassDevice Contributors Network

By Westby G. Fisher, MD, FACC

Westby Fisher

I don’t know what I was thinking with my last post about the Health and Human Services’ Million Hearts initiative. I thought the whole point of this program was to save money. At the time, I was less than optimistic that the government could accurately reach their goal given the problems with many of the principles behind their program. For instance, maybe it was just me, but how typing on an electronic medical record system would save those lives was lost on me.

But at the time, I had no idea this whole campaign was based on fear.

Watch this introductory video I found on the brand new Million Hearts website, all paid for (of course) with your tax payer dollars:

Listen to all that horrible stuff that can happen to you! And they look like such nice, ordinary people. Man, if that doesn’t scare you into seeing your doctor, I don’t know what will!

I have now seen the light: this is going to be awesome! (* Cha-ching! *)

You know: terrified, low risk people clamoring for an appointment insisting on all kinds of blood draws, testing, EKGs, and sophisticated imaging tests! And for all those tests with false positives, maybe an angio, too! We’re about to make a fortune on this program all in the name of “cost savings!” Baby, there’s NOTHING like screening low risk people when it comes to making money: Yeeeeeee haaaaaa!

Boys and girls, step right up! Help our heath care system save money, will you? (* Yuck yuck yuck *) After all (wink wink) it’s about saving a million lives! You did see that video above, didn’t you? No? Make sure you do: this is really BAD stuff!

Boy, no WONDER the American Medical Association, the American Heart Association, the American College of Cardiology, Walgreens, United Healthcare and a whole host of other “private interests” want to support this program: it’s not just about the hearts, it’s about the Benjamins!

Even better: they’re on Facebook and Twitter! (Hope their video goes viral! Pssst: here’s the link: http://www.youtube.com/embed/poc1eTuJJfc)

Absolutely, positively, brilliant. (I hope our health care system’s marketing team is watching.)

After all, nothing sells like fear.

-Wes

Filed Under: News Well Tagged With: Dr. Wes

More recent news

  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Preceptis Medical has a new CEO as it advances ear tube tech
  • FDA clears first over-the-counter cuffless blood pressure monitor
  • Mendaera wins FDA clearance for robotic needle placement
  • Johnson & Johnson seeks to have $442 million antitrust verdict tossed out

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy